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ABSTRACT 
 
The hepatoprotective potential of standardized Feronia limonia (Family, Rutaceae) methanol-
ic extract (FL-7) and chloroform soluble fraction (FL-9) were assessed against carbon tetra-
chloride (CCl4) induced oxidative stress and hepatotoxicity in rats. Rats treated with CCl4 re-
corded significant elevation in plasma markers of hepatic injury, alteration in hepatic antioxi-
dant status and histopathological damages. However, rats pretreated with FL-7 (200 or 
400 mg/kg, p.o.) and FL-9 (100 or 200 mg/kg, p.o.) for 7 days and later administered CCl4 
(0.5 ml/kg, i.p.) recorded lowered indices of the above mentioned parameters and minimal 
histological damage in a dose dependent manner. These results were comparable to that of 
CCl4+silymarin treated rats. The results obtained with FL-7 and FL-9 are attributable to their 
free radical scavenging potential due to high contents of polyphenols and flavonols recorded 
herein. Overall, this study establishes the efficacy of FL-7 and FL-9 as hepatoprotective 
agents against CCl4 induced hepatotoxicity in rats. 
 
Keywords: carbon tetrachloride, silymarin, Feronia limonia, histopathology  
 
Abbreviations: - AST: Aspartate amino transferase, ALT: Alanine amino transferase, CCL4: 
Carbon tetrachloride, BW: Bodyweight, w/w: Weight/weight, OECD: Organization for Eco-
nomic Co-operation and Development, ALP: Alkaline phosphatase, SOD: Superoxide dis-
mutase, CAT: Catalase. GSH: Reduced glutathione, LPO: Lipid peroxidation, MDA: Malo-
naldehyde, AA: Ascorbic acid 
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INTRODUCTION 
Liver carries out three major physiolog-
ical processes viz. production of bile, me-
tabolism of nutrients and elimination of 
metabolic waste. Additionally, it is in-
volved in detoxification and subsequent 
elimination of drugs and xenobiotics 
(Saleem et al., 2010). Incidences of chemi-
cal/drug induced hepatotoxicity are on the 
rise and provoke a need for a safe hepato-
protective agent in lieu of synthetic coun-
terparts. Traditional Indian systems of med-
icine such as Ayurveda, Siddha and Unani 
have gained importance and popularity in 
recent years because of their safety, effica-
cy and cost effectiveness (Kumar, 2012). 
Several Indian medicinal plants have been 
listed in the Indian traditional system of 
medicine with claims of treating disorders 
associated with liver and also imparting 
hepatoprotection (Saleem et al., 2010, Ku-
mar et al., 2012).  
Standardization of herbal formulations 
is essential in order to assess their quality, 
efficacy and possible side effects (Jain et 
al., 2010). But, use of folklore herbal prep-
arations as an alternative medicine is seri-
ously hampered because they often lack 
scientific validity, phytochemical character-
ization and reproducibility of results (Sa-
hoo et al., 2010). Identification and charac-
terization of markers/bioactive compounds 
present in herbal extract is therefore man-
datory as per the regulatory guidelines 
(Choudhary and Sekhon, 2011). Chemical 
fingerprints obtained by chromatographic, 
spectroscopic, thermo-gravimetric analysis, 
capillary electrophoresis and polarography 
techniques have become the most potent 
tools for quality control of traditional herb-
al medicines (Jain et al., 2011a). 
Feronia limonia. L (Family Rutaceae, 
subfamily Aurantioideae), commonly 
known as wood-apple, elephant apple, 
monkey fruit, curd fruit etc. is widely dis-
tributed in dry warm regions of India, 
Bangladesh, Myanmar, Java & Srilanka 
(Qureshi et al., 2010). Fruit, gum, leaves, 
bark and pulp of FL have been reported to 
possess wide array of pharmacological 
properties (Qureshi et al., 2010). Phyto-
chemical characterization of FL leaves has 
shown presence of coumarins (luvangetin, 
xanthotoxin and marmesin), triterpenoids 
(lupeol and limonin), steroids (sitosterol 
and sitosterol-O- β-D-glucoside) and essen-
tial oil (methyl chavicol, linalool etc.) 
(Qureshi et al., 2010).  
Previous studies have reported hepato-
protective potential of crude FL leaf extract 
against thioacetamide, allyl alcohol (Man-
jusha et al., 2004), paracetamol (Ahamed et 
al., 2010), D-galactosamine and lipopoly-
saccharide (Ahamed et al., 2011) induced 
hepatotoxicity in rats. However, these stud-
ies lack details pertaining to the characteri-
zation and phytochemical constituents of 
FL extract. Hence, it is not possible to pre-
dict the compound/s or their mixtures re-
sponsible for imparting hepatoprotection. 
Recently, we had reported in vitro hepato-
protective potential of bioassay guided 
characterized extract/fractions of FL leaf 
(Jain et al., 2011b). In continuation of this 
study, this inventory is an effort to evaluate 
efficacy of standardized FL leaf extracts 
(methanolic and chloroform soluble frac-
tions) in ameliorating carbon tetrachloride 
induced oxidative stress and hepatotoxicity 
in rats. 
 
MATERIAL AND METHODS 
Chemicals 
CCl4 and others solvents, were of ana-
lytical grade purchased from Merck India 
Ltd, Mumbai, India. Silymarin was ob-
tained from Admac Pharma, India. All the 
diagnostic kits were purchased from Reck-
on Diagnostics, Baroda, India. 
 
Plant material 
Feronia limonia leaves were collected 
in the months of September–October 2008 
from campus of The M. S. University of 
Baroda, Vadodara, India, authenticated in 
the Botany Department and a voucher spec-
imen (No. Pharmacy/FL/ 08-09/01/MJ) was 
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deposited in the Pharmacy Department of 
the university. 
 
Extraction and fractionation 
The leaves were shade dried, powdered 
(500 g) and extracted three times with pe-
troleum ether (3X1.5 L) in a soxhlet appa-
ratus. The filtrates were then combined and 
filtered and concentrated to dryness in a 
rotary evaporator (Buchi-R-215, Germany) 
to obtain a crude petroleum ether extract 
[9.5 g (1.90 % w/w)]. The remaining marc 
was then dried and again exhaustively ex-
tracted at temperature (60-80 °C) with 
methanol (3 × 1.5 L) in a soxhlet apparatus. 
The pooled extracts obtained were then 
concentrated under vacuum to give meth-
anolic extract (FL-7) [27 g (5.07 % w/w]. 
This extract was re-dissolved in water: 
methanol and partitioned with organic sol-
vents to provide a chloroform fraction (FL-
9) [4.6 g (0.92 % w/w)]. 
 
Preparation of extract, fraction and 
standard solutions for HPLC 
Standard marmesin (5 mg) was weighed 
in separate volumetric flasks and dissolved 
in 5 ml methanol to prepare a stock solution 
of 1000 µg/ml. The same were serially di-
luted with methanol to obtain a range of 
20–100 µg/ml. Sample extract  and fraction 
(10 mg each) were weighed in separate 
volumetric flasks and dissolved in 10 ml 
methanol to obtain a stock concentrations 
of 1000 µg/ml. 
 
HPLC fingerprinting of extract and frac-
tion  
Methanolic extract and chloroform frac-
tion of FL leaves along with marmesin 
were subjected to HPLC analysis 
(Spinchrom Chromatographic Station® 
CFR Version 2.4.0.193, Chennai, India) 
with a SPD M20A photo-diode array 
(PDA) detector to obtain a chromatogram. 
Hypersil C18 column (particle size 5 mm; 
250 ´ 4.6 mm id; Thermoquest, Cheshire, 
UK) proceeded by an ODS (Thermoquest) 
guard column (10 mm, 10 ´ 5 mm id) at an 
ambient temperature was used. FL-7 and 
FL-9 were filtered through a 0.45 µM filter 
disk.  Each sample (20 µl) was injected on-
to the column and monitored at 280 nm. 
Peak obtained in the UV spectra thus con-
firmed purity. The mobile phase consisting 
of methanol: water (1:1) was run at room 
temperature (flow rate = 2 Ml/min) for 
20 min. The procedure was repeated three 
times for each sample. Calibration curve 
for marmesin was prepared using calibra-
tion solution (in range of 10-50 µg/ml) 
(Jain et al., 2011a). Each solution was in-
jected in triplicate and a calibration curve 
was prepared using mean values. Concen-
tration of marmesin was expressed in terms 
of % w/w. 
 
In vitro antioxidant activity of FL-7 and 
FL-9 by DPPH assay 
Free radical-scavenging activity of FL-
7 and Fl-9 was determined by the 1,1-
diphenyl-2-picrylhydrazyl (DPPH•) assay 
as described previously by Jadeja et al. 
(2009). Briefly, the bleaching rate of a sta-
ble free radical, DPPH• is monitored at a 
characteristic wavelength (517 nm) in the 
presence of the FL-7 and FL-9. One ml of 
DPPH (0.08 mM) was added to 0.3 ml of 
FL-7, FL-9 or AA (10-100 µg/ml). The re-
action mixture was mixed thoroughly and 
allowed to stand at room temperature for 
30 min, and later was read at 517 nm on 
UV-VIS spectrophotometer against dis-
tilled water blank. 
 
Experimental animals 
Age matched (8-10 weeks old) male 
Wistar rats weighing 280±20 (obtained 
from Zydus Research Centre, Ahmedabad, 
Gujarat, India) were housed and maintained 
in clean polypropylene cages and fed with 
laboratory chow (Pranav Agro Ltd., India). 
Experiments were carried out according to 
the guidelines of the Committee for the 
Purpose of Control and Supervision of Ex-
periments on Animals (CPCSEA), India 
and approved by the institutional animal 
ethical committee (IAEC) of the Depart-
ment of Pharmacy, Faculty of Technology 
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and Engineering, The M. S. University of 
Baroda, Vadodara, INDIA. 
 
Acute toxicity studies 
Acute oral toxicity study was conducted 
using the limit test procedure as per the 
OECD test guidelines on acute oral toxicity 
test 401 (OECD, 2001). Sixty four Wistar 
rats of either sex were divided into eight 
groups (n=8) and were orally administered 
with a single dose of 1000 mg, 2000 mg, 
3000 mg or 5000 mg body weight of FL-7 
or FL-9. Animals were observed for possi-
ble behavioral changes such as tremors, 
convulsions, sleep, altered feeding, saliva-
tion, altered somato-motor activities and 
diarrhea. 
 
CCl4 induced hepatotoxicity in rats 
Forty two rats were randomly divided 
into 7 groups of 6 each. Group – I (CON) 
served as normal control and was orally 
given 0.5 % carboxy methyl cellulose 
(CMC) solution (0.1 ml) once daily for 7 
days. Group – II (CCl4) was given 0.5 % 
CMC solution (0.1 ml) once daily for 7 
days. Group – III and IV (CCl4+FL-7A and 
CCl4+FL-7B) were orally given 200 or 
400 mg/kg BW of FL-7 extract once daily 
for 7 days respectively. Group – V and VI 
(CCl4+FL-9A and CCl4+FL-9B) were oral-
ly given 100 or 200 mg/kg BW once daily 
for 7 days, respectively. Group – VII 
(CCl4+SYL) was orally given 25 mg/kg of 
silymarin (Jadeja et al., 2011) once daily 
for 7 days. Groups II, III, IV, V, VI and VII 
were injected with a single dose of CCl4 
(0.5 ml/kg i.p.) on 7th day of the study 
(Jadeja et al., 2011) whereas, Group I was 
given equal volume of olive oil (vehicle). 
On the 8th day, blood samples were col-
lected from overnight fasted rats via retro-
orbital sinus puncture under mild ether an-
esthesia and the plasma separated for bio-
chemical analysis. Later, animals were sac-
rificed by cervical dislocation under mild 
ether anesthesia and liver was excised and 
stored at -80 °C for further estimations. 
Plasma biochemical analysis 
Plasma AST, ALT, ALP, total bilirubin 
and total protein were assayed using com-
mercially available kits (Reckon diagnos-
tics, Baroda, India). 
 
Hepatic antioxidants and lipid peroxida-
tion 
Liver of control and treated animal 
were excised, weighed and homogenized in 
chilled tris buffer (10 mM, pH 7.4) at a 
concentration of 10 % (w/v). The homoge-
nates were then centrifuged at 10,000×g at 
0 °C for 20 min in high speed cooling cen-
trifuge. Supernatants were used for the as-
say of SOD (Kakkar et al., 1984), CAT 
(Sinha, 1972), GSH (Beutler et al., 1963), 
total protein (Lowry et al., 1951) and LPO 
(Buege and Aust, 1978) whereas, ascorbic 
acid content was determined in sediment by 
Roe and Küether, 1943. 
 
Microscopic evaluation of hepatic tissue 
Liver samples were fixed in 4 % buff-
ered paraformaldehyde, dehydrated in 
graded alcohol series and embedded in par-
affin wax. Five μm thick sections were cut 
and stained with hematoxyline and eosin 
and examined for gross structural changes. 
Observations were done under Leica mi-
croscope and photographs were taken with 
Canon power shot S72 digital Camera (200 
X). 
 
Statistical analysis 
Data was analyzed for statistical signif-
icance using one way analysis of variance 
(ANOVA) followed by Bonferroni’s multi-
ple comparison test and results were ex-
pressed as mean ± S.E.M using Graph Pad 
Prism version 3.0 for Windows, Graph Pad 
Software, San Diego, CA, USA. 
 
RESULTS 
HPLC fingerprinting of extract and frac-
tion 
The methanolic extract (FL-7) showed 
11 peaks with varying retention times 
(0.737, 2.183, 2.443, 2.827, 3.657, 4.117, 
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5.193, 7.887, 12.610, 13.710 and 17.643) 
(Figure 1). The acetone fraction (FL-9) 
showed 9 peaks at varying retention times, 
(0.147, 2.143, 2.443, 2.827, 3.657, 5.193, 
7.887, 12.610 and 17. 643) (Figure 1). The 
chromatogram obtained for FL-7 and FL-9 
revealed multiple peaks including that of 
marmesin (Retention time, 7.847).  
 
Quantification of marmesin by HPLC 
Developed methods were applied to de-
termine the marmesin in the leaf extract 
(FL-7) and chloroform fraction (FL-9) of F. 
limonia. The chromatogram obtained for 
marmesin (Figure 1A), FL-7 (Figure 1B) 
and FL-9 (Figure 1C) showed a separate 
distinct peak for marmesin (Retention time, 
7.847 min). The calibration curve was pre-
pared with marmesin and was found to be 
linear (R2 = 0.988) in the concentration 
range used (10–50 mg/ml). The presence of 
marmesin in FL-7 and FL-9 were found to 
be 4.71 ± 0.02 and 6.82 ± 0.04 mg/g.  
 
 
 
 
 
Figure 1: HPLC chromatogram of marmesin (A) F. limonia leaf methanolic extract (B), chloroform 
fraction (C) showing presence of marmesin (Retention time; 7.847 min).  
 
HPLC process parameter of marmesin, FL-7 and FL-9 (mobile phase, Methanol-water; 50: 50, flow 
rate; 2 ml/min, detection; UV at 280 nm, Retention time 7.847 minutes 
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DPPH radical scavenging assay 
As shown in Figure 2, FL-7 and FL-9 
demonstrated dose dependent DPPH radical 
scavenging activity with inhibition concen-
tration (IC50) of 60±1.40 and 76±1.52 
µg/ml, respectively, whereas IC50 of AA 
was found to be 24.32±0.98 µg/ml (Figure 
2). 
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Figure 2: DPPH radical scavenging potential of 
F. imonia leaf methanolic extract (FL-7), chloro-
form fraction (FL-9). 
Results are expressed as mean ± S.D for n=3 
and error bar represents standard deviation.  
 
Acute toxicity studies 
No mortality was recorded in animals 
that were orally administered with single 
dose (1000, 3000 or 5000 mg/kg) of FL-7 
or FL-9. There were also no adverse behav-
ioral changes or food aversion was ob-
served. Also, other ailments like excessive 
salivation or diarrhea were not observed in 
all the treatment groups.  
 
Hepatic antioxidants and lipid peroxida-
tion 
As shown in Table 1, there was signifi-
cant decrement in activity levels of hepatic 
SOD (60.26 %) and CAT (52.40 %) and 
contents of GSH (62.50 %) and AA 
(52.26 %) in CCl4 treated rats compared to 
control. However, CCl4 treatment to FL7 or 
FL-9 pretreated rats recorded minimal 
changes in these parameters comparable to 
that of control rats. Hepatic LPO levels 
were significantly high (%) in CCl4 treated 
groups compared to control rats. However, 
LPO levels of rats pretreated with FL-7, 
FL-9 or SYL was comparable to that of the 
control (Table 1).  
 
 
Table 1: Effect of F. limonia leaf methanolic extract (FL-7), chloroform fraction (FL-9) and silymarin 
(SYL) on hepatic antioxidants and lipid peroxidation 
 
Experimental 
groups 
SOD 
(U/min/mg 
protein) 
CAT 
(U/min/mg 
protein) 
GSH 
(mg/g) 
AA 
(mg/g) 
LPO 
(nmol of MDA 
/mg protein) 
Control 65.11 ± 3.13 32.21 ± 1.13 6.00 ± 0.31 4.19 ± 0.07 2.98 ± 0.04 
0.5 ml/kg CCl4 25.87 ± 1.17C 15.33±0.66C 2.25 ± 0.03C 2.00 ± 0.05C 5.42 ± 0.05C 
SYL (25 mg/kg) 
+0.5 ml/kg CCl4 
57.01 ± 2.33c 30.68 ± 1.60c 5.00 ± 0.05b 3.78 ± 0.06c 2.29 ± 0.03c 
FL-7 (200mg/kg) 
+0.5 ml/kg CCl4 
44.33 ± 1.20c 24.00 ± 0.58b 3.91 ± 0.02b 2.96 ± 0.01c 3.15 ± 0.02b 
FL-7 (400mg/kg) 
+0.5 ml/kg CCl4 
48.23 ± 0.88c 26.00 ± 0.31c 4.54 ± 0.03c 2.65 ± 0.28c 2.67 ± 0.03c 
FL-9 (100mg/kg) 
+0.5 ml/kg CCl4 
46.35 ± 0.88c 24.33 ± 0.33b 4.13 ± 0.07c 3.25 ± 0.01c 2.67 ± 0.02c 
FL-9 (200mg/kg) 
+0.5 ml/kg CCl4 
50.10 ± 0.52c 27.00 ± 0.59c 4.85 ± 0.04c 3.72 ± 0.02c 2.37 ± 0.04c 
Data expressed as mean ± S.E.M. for n=6, where Cp<0.001 compared to control and bp<0.01 and 
cp<0.001 compared to CCl4 
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Table 2: Effect of F. imonia leaf methanolic extract (FL-7), acetone fraction (FL-9) and silymarin (SYL) 
on hepatic antioxidants and lipid peroxidation 
Data expressed as mean ± S.E.M. for n=6, where Cp<0.001 compared to control and ap<0.05, bp<0.01 
and cp<0.001 compared to CCl4 
 
 
Plasma markers of hepatic injury 
Treatment of CCl4 to rats recorded sig-
nificantly elevated level of plasma AST 
(74.11 %), ALT (66.32 %), ALP (53.59 %) 
and total bilirubin (67.5 %) whereas, the 
total protein (43.43 %) content was signifi-
cantly reduced compared to control rats 
(Table 2). However, FL7 or FL-9 pre-
treatment significantly (p<0.05) prevented 
CCl4 induced elevation in plasma markers 
of hepatic injury and decrement in plasma 
total protein. The results were comparable 
to that of SYL+CCl4 rats (Table 2). 
 
Microscopic evaluation of liver 
Intra cellular lipid accumulation, ap-
pearance of ballooning hepatocytes, heap-
tocytes necrosis and infiltration of inflam-
matory cells were the characteristic features 
of liver section of CCl4 treated group (Fig-
ure 3).  
 
 
 
Figure 3: Haematoxyline-eosin stained photomicrographs of rat liver treated with either vehicle (con-
trol) or CCl4 (0.5 ml/kg) alone or F. limonia 200 or 400 mg/kg leaf methanolic extract (FL-7A and FL-
7B), 100 or 200 mg/kg chloroform fraction (FL-9A and FL-9B) or 50 mg/kg silymarin (SYL) pre-
treatment followed by CCl4 (0.5 ml/kg). Where scale bar represents 50 µm, green arrow; healthy 
population of hepatocytes, black arrow; infiltration of inflammatory cells and red arrow; fatty degenera-
tion of hepatocytes 
Experimental 
groups 
ALT  
(U/L) 
AST  
(U/L) 
ALP  
(U/L) 
Total pro-
tein (g/dl) 
Bilirubin 
(g/dl) 
Control 47.52 ± 1.23 83.11 ± 1.65 1.55 ± 0.02 7.62 ± 0.03 1.30 ± 0.01 
0.5 ml/kg CCl4 141.10 ± 2.25C 321.13 ± 4.99C 3.34 ± 0.02C 4.31 ± 0.04C 4.00 ± 0.04C 
SYL (25 mg/kg) 
+0.5 ml/kg CCl4 
51.12 ± 1.55c 90.22 ± 4.67c 1.51 ± 0.01b 7.31 ± 0.03c 1.39 ± 0.02c 
FL-7 (200mg/kg) 
+0.5 ml/kg CCl4 
67.83 ± 2.26c 131.33 ± 4.06b 2.38 ± 0.04b 6.35 ± 0.03b 2.22 ± 0.02a 
FL-7 (400mg/kg) 
+0.5 ml/kg CCl4 
58.5 ± 3.00c 112.00 ± 2.06c 2.21 ± 0.02b 6.86 ± 0.08c 1.94 ± 0.01b 
FL-9 (100mg/kg) 
+0.5 ml/kg CCl4 
59.66 ± 4.14c 111.83 ± 2.56b 2.10 ± 0.04b 6.87 ± 0.03b 1.84 ± 0.03c 
FL-9 (200mg/kg) 
+0.5 ml/kg CCl4 
52.00 ± 3.81c 99.16 ± 4.69c 1.91 ± 0.02c 7.58 ± 0.04c 1.48 ± 0.02c 
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These cellular changes were greatly re-
duced in FL-7 and FL-9 pre-treated rats 
wherein, few scattered ballooning hepato-
cytes and mild evidence of hepatocyte lipid 
accumulation and inflammation was seen. 
The same was comparable with the liver 
sections of SYL+CCl4 rats (Figure 3). 
 
DISCUSSION 
A wide variety of phytochemical com-
pounds has been isolated from roots and 
aerial parts of FL leaves. Recently, studies 
from our laboratory had reported presence 
of marmesin (a coumarin) in FL extract that 
can be used for standardization of extracts 
prepared from different parts of FL (Jain et 
al., 2010, 2011a, 2012). Also, in vitro 
screening of bioassay guided fractions of 
FL had revealed that methanolic extract and 
its chloroform soluble fractions were bio-
logically potent in imparting hepatoprotec-
tion (Jain et al., 2011b). Hence, it was 
thought pertinent to evaluate in vivo hepa-
toprotective potential of FL leaf methanolic 
extract and chloroform soluble fraction. 
Carbon tetrachloride induced hepatotoxici-
ty in rats is a well established experimental 
model for screening of hepatoprotective 
herbals and the same was used in our study. 
The hepatotoxic effect of CCl4 is reported 
to be initiated as a result of its reductive 
dehalogenation by hepatic cytochrome 
P450 2E1 forming highly reactive tri-
chloromethyl radical (.CCl3). In the pres-
ence of oxygen .CCl3 gets converted into a 
trichloromethyl peroxyl radical (.OOCCl3). 
These metabolites of CCl4 in turn results in 
hepatic oxidative stress, severe damage to 
mitochondria and nuclei, hepatic fibrosis 
ultimately culminating in necrotic cell 
death (Ferreira et al., 2010). Abstraction of 
hydrogen atoms from poly unsaturated fatty 
acids of cell membrane by CCl3 and 
OOCCl3 initiates the process of lipid perox-
idation (LPO). Further, .CCl3 is also capa-
ble of reacting with the sulfhydryl group of 
reduced glutathione (GSH) resulting in ab-
normal function (Recknagel et al., 1992; 
Halim et al., 1997). This condition of di-
minished antioxidants and heightened lipid 
peroxidation results in consumption of en-
zymatic antioxidants (SOD and CAT) to 
maintain cellular oxidative stress. Presently 
recorded significantly lowered levels of he-
patic antioxidants coupled with high indi-
ces of lipid peroxidation are in agreement 
with earlier reports (Jadeja et al., 2011; De-
sai et al., 2012) and justify occurrence of 
hepatotoxicity in CCl4 treated rats. Howev-
er, FL-7 and FL-9 pre-supplementation was 
capable of imparting significant protection 
against CCl4 induced antioxidant imbalance 
in a dose dependent manner. These results 
can be attributed to potent free radical 
scavenging ability of FL-7 and FL-9 re-
ported herein.  
CCl4 causes altered permeability of 
membrane resulting in leakage of hepatic 
marker enzymes (AST and ALT) from cells 
into the circulation. Hence, elevation in 
levels of these enzymes in plasma acts as a 
reliable marker for assessing hepatotoxicity 
(Firdous et al., 2012). Significantly elevat-
ed levels of plasma ALT, AST, ALP and 
bilirubin and decrement in the total protein 
content were recorded following CCl4 
treatment. Increase in plasma level of ALP 
in CCl4 treated rats could be due to its in-
creased synthesis in presence of elevated 
biliary pressure and subsequent increment 
in bilirubin.  Decrement in total serum pro-
tein recorded herein following CCl4 treat-
ment results due to decreased number of 
functional hepatocytes (Firdous et al., 
2012). However, pretreatment with FL-7 
and FL-9 significantly minimized these set 
of changes indicating at their membrane 
stabilizing potential. High content of flavo-
noids, polyphenols and flavonol in the FL 
extract could be the possible causative 
agents responsible for the observed effect.  
Liver sections of CCl4 treated rats were 
characterized by significant intracellular 
lipid accumulation, formation of ballooning 
hepatocytes, infiltration of inflammatory 
cells and hepatocyte necrosis. These histo-
pathological changes are in agreement with 
previous reports on CCl4 induced hepato-
toxicity (Jadeja et al., 2011; Desai et al., 
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2012) and also corroborate the biochemical 
findings envisaged herein. However, FL-
7+CCl4 and FL-9+CCl4 groups recorded 
minimal changes in the structure of hepato-
cytes and were comparable with SYL+CCl4 
group. 
 
CONCLUSION 
It can be concluded from the present 
study that standardized methanolic extract 
and chloroform soluble fraction of FL 
leaves is capable of imparting hepatopro-
tection against CCl4 induced hepatotoxicity 
in rats and can be developed as an herbal 
hepatoprotective formulation. 
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